Table 2 |
|||
|
Receptors and signaling proteins associated with semaphorins |
|||
| Semaphorin |
Binding receptors (with representative references) |
Signaling proteins (with representative references) |
'Reverse' signaling (with representative references) |
|
|
|||
| Sema-1a |
PlexA [158,159] |
OTK [168], Gyc76c [169], MICAL [170], Nervy [171], PKA [171], Rac [172] |
ena [50] |
| Sema-1b |
PlexA [158] |
- |
- |
| Sema-2a |
- |
- |
- |
| Sema-2b |
- |
- |
- |
| Sema3A |
Npn-1 [160,161], proteoglycans [162] |
PlexA1, A2, A3, A4 [165,173,174], PlexD1 [175], VEGF receptor [176], L1CAM [177],
integrins [61], α2-chimaerin [178], Cdc42 [179], Cdk5 [180], cGKI/PKG [181,182], Calcium
channels [12], cofilin [183], CRAM [184], CRMP [185], FARP2 [45], Fes [184], Fyn [180],
Go/Gi [185], guanylate cyclase [186], GSK-3 [187], LIM kinase [183], 12/15-lipoxygenase
[188], MAP kinases [176], MLCK [189], nNOS [190], PI 3-kinase [181], PIPKIγ661 [45],
PKA [181], PTEN [191], Rac [192], Rap1 [193], Rho [194], Rnd [195], ROCK [181], R-Ras
[45] |
- |
| Sema3B |
Npn-1 [125], Npn-2 [125] |
NrCAM [126], FAK [126], MAP kinases [126], Src [126] |
- |
| Sema3C |
Npn-1 [163], Npn-2 [163] |
PlexD1 [196], MLCK [189], ROCK [189] |
- |
| Sema3D |
Npn-1 [164] |
- |
- |
| Sema3E |
Npn-1 [164], PlexD1 [130] |
Ca2+ channels [129], MAP kinases [129], PKC [129], Ras [129] |
- |
| Sema3F |
Npn-2 [163], Npn-1 [163] |
PlexA3, A4 [173,174], NrCAM [127], E-cadherin [197], Beta-catenin [197], PI 3-kinase
[198], MAP kinases [198] |
- |
| Sema3G |
Npn-2 [83] |
- |
- |
| Sema4A |
Tim-2 [84] |
ROCK [139] |
- |
| Sema4B |
- |
- |
PSD-95 [87] |
| Sema4C |
- |
- |
PSD-95 [90], GIPC [207], norbin [208] |
| Sema4D |
PlexB1 [165], PlexB2 [166], CD72 [167] |
Met [147], Ron [199], ErbB2 [200], PlexC1 [34], integrin [201], AKT [141], Gab1 [147],
LARG [146], 12/15-lipoxygenase [201], p190RhoGAP [202], PDZ-RhoGEF [146], PI 3-kinase
[141], Pyk2 [141], Ras [46,203], Rho [204], Rnd [205], Src [141], MAP kinases [203],
Raf [203] |
CD45 [142], serine kinase [209] |
| Sema4E |
- |
- |
- |
| Sema4F |
- |
- |
PSD-95 [95] |
| Sema5A |
PlexB3 [149], HSPG [16], CSPG [16], Syn-3 [16] |
Met [149] |
- |
| Sema5B |
- |
- |
- |
| Sema5C |
- |
- |
- |
| Sema6A |
PlexA4 [151] |
- |
EVL [15] |
| Sema6B |
PlexA4 [151] |
- |
Src [39] |
| Sema6C |
- |
- |
- |
| Sema6D |
PlexA1 [152] |
OTK [152], VEGF receptor 2 [152] |
Abl [46] |
| Sema7A |
PlexC1 [165] |
Integrins [154], Arg [206], FAK [154], MAP kinases [154] |
Kinase activity [4] |
| SemaVA |
PlexC1 [156] |
Integrins [31], cofilin [31], FAK [31] |
- |
| SemaVB |
PlexC1 [156] |
- |
- |
|
|
|||
|
A hyphen indicates not known. Abbreviations: Abl, Abelson tyrosine kinase; AKT, AKT serine/threonine kinase; Arg, Abl-related tyrosine kinase; CAM, cell adhesion molecule; CD45, CD45 phosphatase; Cdk5, cyclin-dependent kinase 5; CRAM, CRMP-associated molecule; CRMP, collapsing response mediator protein; cGKI, cGMP dependent protein kinase I; CSPG, chondroitin sulfate proteoglycan; ErbB2, receptor tyrosine kinase; ena, enabled; EVL, ena/VASP-like protein; FAK, focal adhesion tyrosine kinase; FARP2, FERM domain-containing GEF; Fes, feline sarcoma tyrosine kinase; Fyn, Fyn tyrosine kinase; Gab1, GRB2 associated binding protein 1; GIPC, GAIP interacting protein carboxy terminus; GSK-3, glycogen synthase kinase-3; Gyc76c, receptor guanylate cyclase 76c; HSPG, heparin sulfate proteoglycan; LARG, leukemia-associated RhoGEF; Met, receptor tyrosine kinase; MICAL, molecule interacting with CasL; MLCK, myosin light chain kinase; nNOS, neuronal nitric oxide synthase; Npn, neuropilin; OTK, off-track receptor tyrosine kinase; PI 3-kinase, phosphatidylinositol 3-kinase; PIPKIγ661, PIP kinase type I; PKA, protein kinase A; PKC, protein kinase C; PKG, protein kinase G; Plex, plexin; Pyk2, Pyk2 tyrosine kinase; PSD-95, post-synaptic density protein; PTEN, PTEN phosphatase; ROCK, Rho-associated kinase; Ron, receptor tyrosine kinase; Src, Src tyrosine kinase; Syn-3, syndecan-3; Tim, T-cell immunoglobulin domain and mucin domain; VEGF, vascular endothelial growth factor. |
|||
|
Yazdani and Terman Genome Biology 2006 7:211 doi:10.1186/gb-2006-7-3-211 |
|||